Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2014
DOI: 10.1016/j.medmal.2014.07.016
|View full text |Cite
|
Sign up to set email alerts
|

Phenotype, genotype, and serotype distribution of macrolide resistant invasive and non-invasive Streptococcus pneumoniae strains, in Sousse, Tunisia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
3
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 20 publications
3
3
0
Order By: Relevance
“…Similar to the other reports from Middle East countries [3, 25] the frequencies of our serotypes included in PCV7 and PCV10 were 89% for clinical, 50% for normal flora and 68% for total sisolates. Serotype 3 was the only non-PCV7 serotype found in our clinical study.…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…Similar to the other reports from Middle East countries [3, 25] the frequencies of our serotypes included in PCV7 and PCV10 were 89% for clinical, 50% for normal flora and 68% for total sisolates. Serotype 3 was the only non-PCV7 serotype found in our clinical study.…”
Section: Discussionsupporting
confidence: 90%
“…Similar to the results obtained in Asia and some European countries [3, 1416], we also found that the most common mechanism (48%) for macrolide resistance in our pneumococcal isolates was ermB-encoded ribosome methylase activity. On the contrary, efflux mediated pump gene ( mef ), which has been reported to be the dominant macrolide resistant in North American countries [1718] and Germany [19], was found only in 20% of our isolates.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Of interest, the presence of serotype 3 (9.2%) was noted in this study. This serotype, described in several countries, has presented a low prevalence in reports from Tunisia and North Africa (Ziane et al, 2016;Charfi et al, 2012;Rachdi et al, 2011;Marzouk et al, 2014Marzouk et al, , 2015Raddaoui et al, 2015;Diawara et al, 2015). As has been reported previously (Martens et al, 2004), serotype 3 was most often isolated from non-invasive diseases in the present study (82.1%).…”
Section: Discussionsupporting
confidence: 81%
“…The choice of vaccine in each country must take into account the circulating serotypes. Current local data on pneumococcal serotypes in Tunisia are limited, and only a few reports from Tunisia have been published in the last decade (Charfi et al, 2012;Rachdi et al, 2011;Marzouk et al, 2014Marzouk et al, , 2015Raddaoui et al, 2015).…”
Section: Introductionmentioning
confidence: 99%